FY2027UpcomingSelected edition
Effective from
- Inherited rules changed
Tuberculosis of intestines, peritoneum and mesenteric glands
Category — select a more specific code
CDC/NCHS · FY2027code to identify resistance to antimicrobial drugs (Z16.-)
code, if applicable, for associated cachexia (E88.A)
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
Latest recorded change · FY2027
Effective from
Tuberculosis of intestines, peritoneum and mesenteric glands
Category — select a more specific code
CDC/NCHS · FY2027| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | Inherited rules changed |
The official Tabular List has no additional instructions at this code level.
Review the instructions inherited from its parent categories below. Inherited instructions ↓
diseases generally recognized as communicable or transmissible
code to identify resistance to antimicrobial drugs (Z16.-)
infections due to Mycobacterium tuberculosis and Mycobacterium bovis
code, if applicable, for associated cachexia (E88.A)
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| A18.0 | Tuberculosis of bones and joints | Category · further specificity required |
| A18.1 | Tuberculosis of genitourinary system | Category · further specificity required |
| A18.2 | Tuberculous peripheral lymphadenopathy | Billable / specific |
| A18.4 | Tuberculosis of skin and subcutaneous tissue | Billable / specific |
| A18.5 | Tuberculosis of eye | Category · further specificity required |
| A18.6 | Tuberculosis of (inner) (middle) ear | Billable / specific |
| A18.7 | Tuberculosis of adrenal glands | Billable / specific |
| A18.8 | Tuberculosis of other specified organs | Category · further specificity required |
Official titles and instructions are preserved in their source language. Official sources ↗